LPC

Lion Point Capital Portfolio holdings

AUM $17.6M
1-Year Est. Return 50.34%
This Quarter Est. Return
1 Year Est. Return
+50.34%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$17.6M
AUM Growth
+$2.87M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
27
New
Increased
Reduced
Closed

Top Buys

1
+$755K
2
+$600K
3
+$484K
4
KURA icon
Kura Oncology
KURA
+$407K
5
CMPS
Compass Pathways
CMPS
+$332K

Top Sells

1
+$1.52M
2
+$951K
3
+$874K
4
FENC icon
Fennec Pharmaceuticals
FENC
+$680K
5
BBIO icon
BridgeBio Pharma
BBIO
+$660K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HUMA icon
26
Humacyte
HUMA
$236M
$145K 0.83%
83,500
SPRB
27
Spruce Biosciences, Inc. Common Stock
SPRB
$95.5M
$8.95K 0.05%
+1,000
1
2